Welcome to the new Tamingthesru

Same great content - new look - improved search

Grand Rounds Recap 9.28.22
Grand Rounds Guest User Grand Rounds Guest User

Grand Rounds Recap 9.28.22

This week we had a tour de force of education goodness. We started off with Dr. Mullen presenting Morbidity and Mortality Conference. This was followed with an updated DKA QI/KT protocol developed by Dr. Shaw and Dr. Glenn. More great faculty Core Content was brought by Dr. Irankunda elucidating high pressure injection injuries. We wrapped up the day with some research nuggets with Dr. Freiermuth.

Read More
Grand Rounds Recap 12.15.21
Grand Rounds Meaghan Frederick Grand Rounds Meaghan Frederick

Grand Rounds Recap 12.15.21

Join us for a recap of this week’s robust Grand Rounds. We have a wide array of topics including biliary pathology, ED operations and how are decisions impact boarding, congenital long QT and Boerhaave syndrome, TTP, and pediatric stridor.

Read More
Droperidol for Agitation in the ED - No Danger to the Dangerous?
Journal Club, Grand Rounds Jeffery Hill, MD M.Ed Journal Club, Grand Rounds Jeffery Hill, MD M.Ed

Droperidol for Agitation in the ED - No Danger to the Dangerous?

Droperidol is a versatile medication with a number of potential uses for patients in the Emergency Department. It is also a medication surrounded in some degree of mystique because of the decision by the FDA in 2001 to issue a black box warning for its use in response to reports of QT prolongation and torsades de pointes. Many at the time (and since) have argued that, despite these case reports, droperidol is a safe and effective medication that can be used for the treatment of agitation, nausea and vomiting, and migraine. We have previously covered much of this background in a previous blog post. In our most recent journal club, we discussed 3 articles that looked at the safety and efficacy of droperidol for treating acutely agitated patients. Take a read and listen below for an in depth look at each of these papers.

Read More